Cargando…

DHRS7 is an immune-related prognostic biomarker of KIRC and pan-cancer

Renal clear cell carcinoma (KIRC) is one malignancy whose development and prognosis have been associated with aberrant DHRS7 expression. However, the catalytic activity and pathophysiology of KIRC are poorly understood, and no sensitive tumor biomarkers have yet been discovered. In our study, we exa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Sheng, Zhao, Zhenyu, Wang, Yuhang, El Akkawi, Mariya M., Tan, Zhennan, Liu, Dongbin, Chen, Guoxiong, Liu, Hu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584615/ https://www.ncbi.nlm.nih.gov/pubmed/36276963 http://dx.doi.org/10.3389/fgene.2022.1015844

Ejemplares similares

Pan-Cancer Analysis Predicts the Immunological and Prognostic Role of ZC3H12C in KIRC
por: Yue, Yanping, et al.
Publicado: (2022)

Pan-cancer analysis of super enhancer-induced PRR7-AS1 as a potential prognostic and immunological biomarker
por: Wang, Rui, et al.
Publicado: (2023)

Pseudogene HSPA7 is a poor prognostic biomarker in Kidney Renal Clear Cell Carcinoma (KIRC) and correlated with immune infiltrates
por: Ding, Chunjin, et al.
Publicado: (2021)

Pan-cancer analysis of the prognostic and immunological role of ANLN: An onco-immunological biomarker
por: Liu, Kejun, et al.
Publicado: (2022)

Prognostic Impact of DHRS9 Overexpression in Pancreatic Cancer
por: Li, Huang-bao, et al.
Publicado: (2020)

A Pan-Cancer Analysis Reveals the Prognostic and Immunotherapeutic Value of ALKBH7
por: Chen, Kaijie, et al.
Publicado: (2022)

An integrative analysis revealing POLD2 as a tumor suppressive immune protein and prognostic biomarker in pan-cancer
por: Cong, Fengyun, et al.
Publicado: (2022)

PPP1R14B Is a Prognostic and Immunological Biomarker in Pan-Cancer
por: Deng, Mingxia, et al.
Publicado: (2021)

Differential Integration of Transcriptome and Proteome Identifies Pan-Cancer Prognostic Biomarkers
por: Schwartz, Gregory W., et al.
Publicado: (2018)

Pan-Cancer Analysis of PIMREG as a Biomarker for the Prognostic and Immunological Role
por: Zhu, Hua, et al.
Publicado: (2021)

Pan-cancer analyses reveal IGSF10 as an immunological and prognostic biomarker
por: Zhou, Yongxia, et al.
Publicado: (2023)

Prognostic and immunological role of SERPINH1 in pan-cancer
por: Zhong, Huage, et al.
Publicado: (2022)

A Comprehensive Analysis of HAVCR1 as a Prognostic and Diagnostic Marker for Pan-Cancer
por: Liu, Sheng, et al.
Publicado: (2022)

Clinical and immunological characteristics of TGM3 in pan-cancer: A potential prognostic biomarker
por: Zhang, Wenqing, et al.
Publicado: (2023)

Downregulation of DHRS9 expression in colorectal cancer tissues and its prognostic significance
por: Hu, Liang, et al.
Publicado: (2015)

Pan-cancer analysis reveals signal transducer and activator of transcription (STAT) gene family as biomarkers for prognostic prediction and therapeutic guidance
por: Cheng, Mei, et al.
Publicado: (2023)

Dynamic prognostic model for kidney renal clear cell carcinoma (KIRC) patients by combining clinical and genetic information
por: Zhao, Huiling, et al.
Publicado: (2018)

Pan-cancer analysis of forkhead box Q1 as a potential prognostic and immunological biomarker
por: Dong, Qiguan, et al.
Publicado: (2022)

Integrated pan-cancer analysis of CSMD2 as a potential prognostic, diagnostic, and immune biomarker
por: Zhang, Huiyun, et al.
Publicado: (2022)

SERPINH1 is a Potential Prognostic Biomarker and Correlated With Immune Infiltration: A Pan-Cancer Analysis
por: Wang, Yu, et al.
Publicado: (2022)

Pan-cancer analyses confirmed the cuproptosis-related gene FDX1 as an immunotherapy predictor and prognostic biomarker
por: Zhang, Chi, et al.
Publicado: (2022)

MMP25-AS1/hsa-miR-10a-5p/SERPINE1 axis as a novel prognostic biomarker associated with immune cell infiltration in KIRC
por: Tan, Peng, et al.
Publicado: (2021)

Auxiliary Diagnosis and Prognostic Value of Dehydrogenase/Reductase 2 (DHRS2) in Various Tumors
por: An, Zhongwu, et al.
Publicado: (2023)

A role for the dehydrogenase DHRS7 (SDR34C1) in prostate cancer
por: Seibert, Julia K, et al.
Publicado: (2015)

Pan-cancer analysis of CREB3L1 as biomarker in the prediction of prognosis and immunotherapeutic efficacy
por: Lin, Zhengjun, et al.
Publicado: (2022)

Transcriptome and pan-cancer system analysis identify PM2.5-induced stanniocalcin 2 as a potential prognostic and immunological biomarker for cancers
por: Zhu, Dong, et al.
Publicado: (2023)

Pan-cancer analysis identifies DDX56 as a prognostic biomarker associated with immune infiltration and drug sensitivity
por: Ruan, Zhaohui, et al.
Publicado: (2022)

Pan-cancer and single-cell analysis reveals FAM83D expression as a cancer prognostic biomarker
por: Yu, Haiyang, et al.
Publicado: (2022)

Comprehensive analysis about prognostic and immunological role of WTAP in pan-cancer
por: Lei, Jiangchu, et al.
Publicado: (2022)

A Pan-Cancer Analysis of the Oncogenic Role of BCL7B: A Potential Biomarker for Prognosis and Immunotherapy
por: Yang, Dinglong, et al.
Publicado: (2022)

Enhancer RNA-driven looping enhances the transcription of the long noncoding RNA DHRS4-AS1, a controller of the DHRS4 gene cluster
por: Yang, Yingying, et al.
Publicado: (2016)

Cell death-related biomarker SLC2A1 has a significant role in prognosis prediction and immunotherapy efficacy evaluation in pan-cancer
por: Wang, Yuhang, et al.
Publicado: (2023)

Alternative polyadenylation reprogramming of MORC2 induced by NUDT21 loss promotes KIRC carcinogenesis
por: Tan, Yuqin, et al.
Publicado: (2023)

Pan-Cancer Study of SHC-Adaptor Protein 1 (SHC1) as a Diagnostic, Prognostic and Immunological Biomarker in Human Cancer
por: Chen, Jianlin, et al.
Publicado: (2022)

CircDHRS3 inhibits prostate cancer cell proliferation and metastasis through the circDHRS3/miR-421/MEIS2 axis
por: Dai, Xiyu, et al.
Publicado: (2023)

DHRS9 Is a Stable Marker of Human Regulatory Macrophages
por: Riquelme, Paloma, et al.
Publicado: (2017)

Abnormal Expression and Prognosis Value of COG Complex Members in Kidney Renal Clear Cell Carcinoma (KIRC)
por: Zhang, Yanjun, et al.
Publicado: (2021)

N7-Methylguanosine Genes Related Prognostic Biomarker in Hepatocellular Carcinoma
por: Regmi, Parbatraj, et al.
Publicado: (2022)

Differential expression of HAVCR2 gene in pan-cancer: A potential biomarker for survival and immunotherapy
por: Li, Hetong, et al.
Publicado: (2022)

Pan-cancer analysis of prognostic and immunological role of DTYMK in human tumors
por: Zhao, Huihui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h2t0llafn1tngd2b3kp7d4rqg1